BRCA e Carcinoma della prostata
Giuseppe Procopio, MD Istituto Nazionale Tumori
Milano
Slide 4
Presented By Himisha Beltran at 2019 Genitourinary Cancers Symposium
International Stand Up to Cancer- PCF Prostate Cancer Dream Team
Presented By Himisha Beltran at 2019 Genitourinary Cancers Symposium
Implications of homologous recombination alterations:
Presented By Himisha Beltran at 2019 Genitourinary Cancers Symposium
Homologous recombination (HR): open questions
Presented By Himisha Beltran at 2019 Genitourinary Cancers Symposium
4. Nuovi Target
4. Nuovi Target
• HRR mutation status was not used for stratification
• Similar benefit regardless of HRR mutation status
• Study was not powered for subgroup analyses
4. Nuovi Target
Slide 11
Presented By Himisha Beltran at 2019 Genitourinary Cancers Symposium
AR signaling is still the major driver of CRPC
Presented By Himisha Beltran at 2019 Genitourinary Cancers Symposium
Strategies to better target the AR
Presented By Himisha Beltran at 2019 Genitourinary Cancers Symposium
Are there tumors that are more resistant to AR pathway inhibition (AR independent)?
Presented By Himisha Beltran at 2019 Genitourinary Cancers Symposium